GVAX tumor vaccine: Will start a Phase I study

Somatix Therapy Corp. ( SOMA) Product: GVAX tumor vaccine that uses a patient's tumor cells, genetically modified with GM-CSF, to stimulate an anti-tumor immune response Indication: Advanced kidney ca...